VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 166 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $61,000 | -80.5% | 6,411 | -76.6% | 0.00% | -66.7% |
| Q2 2020 | $313,000 | +1.3% | 27,404 | -8.4% | 0.00% | 0.0% |
| Q1 2020 | $309,000 | +10.8% | 29,908 | +75.8% | 0.00% | +50.0% |
| Q4 2019 | $279,000 | -79.9% | 17,014 | -76.6% | 0.00% | -66.7% |
| Q2 2018 | $1,387,000 | -67.7% | 72,805 | -71.4% | 0.01% | -70.0% |
| Q1 2018 | $4,291,000 | -29.1% | 254,630 | -36.1% | 0.02% | -23.1% |
| Q4 2017 | $6,055,000 | -32.8% | 398,347 | -20.8% | 0.03% | -33.3% |
| Q3 2017 | $9,008,000 | +2.0% | 503,255 | -7.1% | 0.04% | +2.6% |
| Q2 2017 | $8,833,000 | +126.1% | 541,927 | +94.2% | 0.04% | +137.5% |
| Q1 2017 | $3,907,000 | -69.5% | 279,094 | -65.3% | 0.02% | -69.8% |
| Q4 2016 | $12,827,000 | -11.9% | 804,206 | -8.1% | 0.05% | -14.5% |
| Q3 2016 | $14,565,000 | +564.5% | 875,320 | +346.8% | 0.06% | +520.0% |
| Q2 2016 | $2,192,000 | – | 195,915 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
| ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
| Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
| GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
| 361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
| CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
| BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
| EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |